Cargando…

Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era

BACKGROUND: This study aimed to test the prognostic significance of pathologically confirmed lymph node invasion in metastatic renal cell carcinoma (mRCC) patients in this immunotherapy era. METHODS: Surgically treated mRCC patients were identified in the Surveillance, Epidemiology, and End Results...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scheipner, Lukas, Barletta, Francesco, Cano Garcia, Cristina, Incesu, Reha-Baris, Morra, Simone, Baudo, Andrea, Assad, Anis, Tian, Zhe, Saad, Fred, Shariat, Shahrokh F., Briganti, Alberto, Chun, Felix K. H., Tilki, Derya, Longo, Nicola, Carmignani, Luca, Pichler, Martin, Ahyai, Sascha, Karakiewicz, Pierre I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Urologic Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625944/ https://www.ncbi.nlm.nih.gov/pubmed/37815682 http://dx.doi.org/10.1245/s10434-023-14367-6

Ejemplares similares

In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
por: Scheipner, Lukas, et al.
Publicado: (2023)

Critical Appraisal of Leibovich 2018 and GRANT Models for Prediction of Cancer-Specific Survival in Non-Metastatic Chromophobe Renal Cell Carcinoma
por: Piccinelli, Mattia Luca, et al.
Publicado: (2023)

Demographics, Clinical Characteristics and Survival Outcomes of Primary Urinary Tract Malignant Melanoma Patients: A Population-Based Analysis
por: Morra, Simone, et al.
Publicado: (2023)

Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell Carcinoma
por: Piccinelli, Mattia L., et al.
Publicado: (2023)

Survival of Testicular Pure Embryonal Carcinoma vs. Mixed Germ Cell Tumor Patients across All Stages
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Differences in Cancer-Specific Mortality after Trimodal Therapy for T2N0M0 Bladder Cancer according to Histological Subtype
por: Barletta, Francesco, et al.
Publicado: (2022)

Survival of Testicular Pure Teratoma vs. Mixed Germ Cell Tumor Patients in Primary Tumor Specimens across All Stages
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

Cancer-specific mortality after radical prostatectomy vs external beam radiotherapy in high-risk Hispanic/Latino prostate cancer patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
por: Flammia, Rocco S., et al.
Publicado: (2022)

Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicities
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Incidence rates and contemporary trends in primary urethral cancer
por: Wenzel, Mike, et al.
Publicado: (2021)

North American population-based validation of the National Comprehensive Cancer Network Practice Guideline Recommendations for locoregional lymph node and bone imaging in prostate cancer patients
por: Preisser, Felix, et al.
Publicado: (2018)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review protocol
por: Beyer, Katharina, et al.
Publicado: (2021)

Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2021)

Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Wenzel, Mike, et al.
Publicado: (2023)

Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical Prostatectomy
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Temporal trends, tumor characteristics and stage-specific survival in penile non-squamous cell carcinoma vs. squamous cell carcinoma
por: Wenzel, Mike, et al.
Publicado: (2021)

Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response
por: Grubmüller, Bernhard, et al.
Publicado: (2021)

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
por: Hoeh, Benedikt, et al.
Publicado: (2022)

Attitude towards active surveillance: a cross-sectional survey among patients with uroandrological disorders
por: Capogrosso, Paolo, et al.
Publicado: (2018)

Comparison of Extracorporeal Shock Wave Lithotripsy for Urolithiasis Between Children and Adults: A Single Centre Study
por: Iqbal, Nadeem, et al.
Publicado: (2016)

Diagnostic and prognostic factors in patients with prostate cancer: a systematic review
por: Beyer, Katharina, et al.
Publicado: (2022)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Hoeh, Benedikt, et al.
Publicado: (2021)

External Tertiary-Care-Hospital Validation of the Epidemiological SEER-Based Nomogram Predicting Downgrading in High-Risk Prostate Cancer Patients Treated with Radical Prostatectomy
por: Cano Garcia, Cristina, et al.
Publicado: (2023)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Role of lymphadenectomy during primary surgery for kidney cancer
por: Bekku, Kensuke, et al.
Publicado: (2023)

Grade and stage misclassification in intermediate unfavorable‐risk prostate cancer radiotherapy candidates
por: Sorce, Gabriele, et al.
Publicado: (2022)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

Radiation therapy after radical prostatectomy is associated with higher other-cause mortality
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Effect of prostatic apex shape (Lee types) and urethral sphincter length in preoperative MRI on very early continence rates after radical prostatectomy
por: Wenzel, Mike, et al.
Publicado: (2021)

Effect of Neoadjuvant Chemotherapy on Complications, in-Hospital Mortality, Length of Stay and Total Hospital Costs in Bladder Cancer Patients Undergoing Radical Cystectomy
por: Hoeh, Benedikt, et al.
Publicado: (2022)

MRI as a screening tool for prostate cancer: current evidence and future challenges
por: Würnschimmel, Christoph, et al.
Publicado: (2022)

Bladder cancer stage and mortality: urban vs. rural residency
por: Deuker, Marina, et al.
Publicado: (2020)

Sorafenib in the management of metastatic renal cell carcinoma
por: Guevremont, C., et al.
Publicado: (2009)

A Case of Low-Flow Priapism as a Complication of COVID-19 Infection
por: Ahmed, Saad, et al.
Publicado: (2022)

An Analysis of Google Trends During COVID-19: Determining Public Urological Cancer Concerns
por: Gong, Fred, et al.
Publicado: (2022)

ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?
por: Mori, Keiichiro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_opg1o5vlv62rqd6l7sejvbn33f